Is SMURF or MRK a better dividend investment in 2026?

SMURF currently yields 1926.78% with a 5% 5-year dividend growth rate. MRK yields 2.76% with 8.2% growth. The better choice depends on your goal: SMURF offers higher current income.

What is the dividend yield difference between SMURF and MRK?

SMURF has a forward dividend yield of 1926.78% ($2.00/share annually). MRK yields 2.76% ($3.32/share annually). The yield gap is 1924.02 percentage points.

Home › Compare › SMURF vs MRK

SMURF vs MRK: Dividend Comparison 2026

SMURF yields 1926.78% · MRK yields 2.76%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 SMURF wins by $7025862856.11M in total portfolio value

INVESTMENT

TIME HORIZON10 years

SMURF

● Live price

1926.78%

Share price

$0.10

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$7025862856.17M

Annual income

$6,375,005,662,143,119.00

Full SMURF calculator →

MRK

Merck & Co. Inc.

● Live price

2.76%

Share price

$120.31

Annual div

$3.32

5Y div CAGR

32.7%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$56.8K

Annual income

$9,798.13

Full MRK calculator →

Portfolio growth — SMURF vs MRK

📍 SMURF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	SMURF	MRK
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, SMURF + MRK cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

SMURF pays

MRK pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SMURF

Annual income on $10K today (after 15% tax)

$163,776.49/yr

After 10yr DRIP, annual income (after tax)

$5,418,754,812,821,651.00/yr

MRK

Annual income on $10K today (after 15% tax)

$234.56/yr

After 10yr DRIP, annual income (after tax)

$8,328.41/yr

At 15% tax rate, SMURF beats the other by $5,418,754,812,813,323.00/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SMURF + MRK for your $10,000?

SMURF: 50%MRK: 50%

100% MRK50/50100% SMURF

Portfolio after 10yr

$3512931428.11M

Annual income

$3,187,502,831,076,458.50/yr

Blended yield

90.74%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

SMURF

No analyst data

Altman Z

9.7

Piotroski

2/9

MRK

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$128.54

+6.8% upside vs current

Range: $100.00 — $150.00

Altman Z

4.0

Piotroski

6/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SMURF buys

MRK buys

No recent congressional trades found for SMURF or MRK in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricSMURFMRK

Forward yield	1926.78% ✓	2.76%
Annual dividend / share	$2.00	$3.32 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	32.7% ✓
Portfolio after 10y	$7025862856.17M ✓	$56.8K
Annual income after 10y	$6,375,005,662,143,119.00 ✓	$9,798.13
Total dividends collected	$6979531506.34M ✓	$28.9K
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare

Year-by-year: SMURF vs MRK ($10,000, DRIP)

Year	SMURF Portfolio	SMURF Income/yr	MRK Portfolio	MRK Income/yr	Gap
1← crossover	$203,378	$192,678.23	$11,206	$366.19	+$192.2K → SMURF
2	$3,879,910	$3,662,294.98	$12,650	$502.35	+$3.87M → SMURF
3	$69,447,522	$65,296,018.95	$14,407	$694.19	+$69.43M → SMURF
4	$1,166,599,119	$1,092,290,270.10	$16,585	$967.82	+$1166.58M → SMURF
5	$18,396,486,149	$17,148,225,091.39	$19,342	$1,363.89	+$18396.47M → SMURF
6	$272,409,488,254	$252,725,248,074.73	$22,913	$1,947.19	+$272409.47M → SMURF
7	$3,788,933,724,527	$3,497,455,572,095.86	$27,662	$2,823.89	+$3788933.70M → SMURF
8	$49,517,694,710,819	$45,463,535,625,574.13	$34,159	$4,173.35	+$49517694.68M → SMURF
9	$608,277,751,428,599	$555,293,818,088,023.40	$43,337	$6,308.80	+$608277751.39M → SMURF
10	$7,025,862,856,171,720	$6,375,005,662,143,119.00	$56,776	$9,798.13	+$7025862856.11M → SMURF

SMURF vs MRK: Complete Analysis 2026

SMURF — Stock

Tokens.com Corp. provides blockchain verification services through proof-of-stake technology. The company's technology secures next-generation blockchain networks through Proof-of-Stake technology to support the growth of decentralized finance applications. It invests in Web3 assets and businesses focused on the Metaverse, NFTs, DeFi, and gaming-based digital assets; purchases and stakes tokens; operates in virtually integrated digital real estate business; and holds NFT assets and invests in crypto-based games. The company also provides consulting services. Tokens.com Corp. is headquartered in Toronto, Canada.

Full SMURF Calculator →

MRK — Healthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →

📬

Get this SMURF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SMURF vs SCHD SMURF vs JEPI SMURF vs O SMURF vs KO SMURF vs MAIN SMURF vs JNJ SMURF vs ABBV SMURF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.